IP Library Granted Patent US 8,183,227
Granted Patent B1
US 8,183,227 · App. 13/292,735 · Granted May 22, 2012

Compositions, kits and methods for nutrition supplementation

Assignee: Chemo S. A. France
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,183,227
App. No.
13/292,735
Granted
May 22, 2012
Kind
B1
Abstract

The present invention relates to compositions, kits and methods for the administration of various vitamin, mineral and nutrient compositions, and in a specific embodiment, the compositions, kits and methods may utilize or include vitamin D, iodine, vitamin B1, vitamin B6, vitamin B12, vitamin B2, vitamin B9, vitamin B3, vitamin E, vitamin A, vitamin C, iron, zinc, copper, magnesium, omega 3 fatty acids and one or more pharmaceutically acceptable carriers.

Claims (10)

1. A composition consisting of vitamin D in an amount of about 1000 I.U., iodine in an amount of about 150 μg, vitamin B1 in an amount of about 1.6 mg, vitamin B6 in an amount of about 2.5 mg, vitamin B12 in an amount of about 12 μg, vitamin B2 in an amount of about 1.8 mg, vitamin B9 in an amount of about 1.0 mg, vitamin E in an amount of about 20 I.U., vitamin A in an amount of about 1100 I.U., vitamin C in an amount of about 30 mg, vitamin B3 in an amount of about 15 mg, iron in an amount of about 29 mg, zinc in an amount of about 25 mg, copper in an amount of about 2.0 mg, magnesium in an amount of about 20 mg, omega 3 fatty acids comprising DHA in an amount of about 200 mg, and one or more pharmaceutically acceptable carriers.

2. The composition of claim 1 , wherein said dosage form is a gelcap.

3. The composition of claim 2 , wherein said dosage form is a liquid gelcap.

4. The composition of claim 1 , wherein the source of DHA is algae oil.

5. The composition of claim 4 , wherein the source of the algae oil is microalgae Crypthecodinium cohnii.

6. The composition of claim 1 , wherein said pharmaceutically acceptable carriers include one or more selected from the group consisting of gelatin, sorbitol, glycerin, soybean oil, beeswax, dicalcium phosphate, lecithin oil, vegetable oil, and colorants.

7. The composition of claim 1 , wherein said composition does not contain fish oils.

8. A method comprising providing vitamin, mineral, and omega-3 fatty acid supplementation to a patient in need thereof, wherein said method comprises administering a composition according to claim 1 to said patient.

9. The method of claim 8 , wherein said patient is a female human, and said composition is administered to said female human before pregnancy, during pregnancy, after pregnancy, while breast-feeding, or a combination thereof.

10. The method of claim 8 , wherein said composition is administered once daily.

Assignments (2)
CHANGE OF NAME Recorded Jan 5, 2023
From: CHEMO S.A. FRANCE
To: EXELTIS FRANCE
Reel/Frame 062300/0162 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 21, 2012
From: PERRIN, PHILIPPE; HERRY, GUILLAUME
To: CHEMO S.A. FRANCE
Reel/Frame 027735/0821 →
Continuity (1)
Provisional Application 61505341 · Jul 7, 2011